Evelyn Bromet, a distinguished professor in the Renaissance School of Medicine Department of Psychiatry and Behavioral Science and director of the Epidemiology Research Group, has been named to Research.com’s...
The Renaissance School of Medicine at Stony Brook University will be part of a new medical school consortium in the New York metro region to train young scientists in kidney, urology and hematology research — crucial...
A study that assessed stress, anxiety and depressive symptoms in pregnant women from seven Western countries during the first major wave of the COVID-19 pandemic (April 17 to May 31, 2020) shows that stress from fears...
LCM Facility Will Use $3M of NIH Funding for Equipment and Structural Upgrades The Laboratory for Comparative Medicine (LCM) at the Renaissance School of Medicine at Stony Brook University has received a $3 million...
Rebecca Spiegel, MD, MA, associate professor of neurology at the Renaissance School of Medicine at Stony Brook University and director of the Stony Brook Level 4 Comprehensive Epilepsy Center, was honored with the 2022...
Lauren Maloney, MD wears more hats than most. She’s an attending emergency medicine physician in the Emergency Department of Stony Brook University Hospital. She’s an adjunct Biomedical Engineering (BME) assistant...
The fellowship will help put a spotlight on Farzana Ali's work, which uses data from wearable sensors like Apple Watch or Fitbit to personalize treatment for mental health care.
Dr. Peter Igarashi is an academically accomplished physician-leader with a highly successful track record of clinical program growth and research advancement.
Stony Brook University’s inaugural ProFund Seed Grants — a program designed to fund interdisciplinary teams of researchers seeking to pursue medium- to large-scale, federal funding opportunities — received...
A study showed that from January 2020 to October 2020, there was an overall decrease in screenings worldwide for breast, colorectal and cervical cancers.
Twenty-three members of Stony Brook University’s faculty and staff have received the 2020-2021 State University of New York (SUNY) Chancellor’s Awards for Excellence.
Paul Bingham and colleagues continue to investigate the wide potential of CPI-613, especially its efficacy when used in concert with other drugs to treat cancer.
At least two percent of the population harbors aneurysms — fragile, bubble-like bulges that can occur at weakened areas in the arteries supplying blood flow to the brain. These aneurysms can burst, causing life...